MATCH publications


  1. Incidence and impact of parvovirus B19 infection in seronegative solid organ transplant recipients. Rezahosseini O, Ekenberg C, Møller DL, Sørensen SS, Wareham NE, Perch M, Gustafsson F, Rasmussen A, Kirkby N, Reekie J, Lundgren J, Nielsen SD.
    J Infect Dis. 2021:jiab024. Abstract
  2. Bacterial and fungal bloodstream infections in solid organ transplant recipients: result from a Danish cohort with nationwide follow-up. Clin Microbiol Infect. Møller DL, Sørensen SS, Perch M, Gustafsson F, Rezahosseini O, Knudsen AD, Scheike T, Knudsen JD, Lundgren J, Rasmussen A, Nielsen SD.
    Clin Microbiol Infect. 2021 :S1198-743X(21)00413-4. Epub ahead of print. Abstract


  1. Evaluation of an electronic, patient-focused management system aimed at preventing cytomegalovirus disease following solid organ transplantation. Ekenberg C, da Cunha-Bang C, Lodding IP, Sørensen SS, Sengeløv H, Perch M, Rasmussen A, Gustafsson F, Wareham NE, Kirkby N, Kjaer J, Helleberg M, Reekie J, Lundgren JD.
    Transpl Infect Dis. 2020;22(2):e13252. Abstract
  2. Tuberculosis among Patients Undergoing Solid Organ Transplantation or Dialysis in a Low-Endemic Country, 2004-2017. Helleberg M, Cho D, Ekenberg C, Sørensen S, Rix M, Gustafsson F, Rasmussen A, Perch M, Andersen PHS, Lundgren JD, Andersen AB.
    Tuberc Res Treat. 2020;2020:7636975. Abstract
  3. Pretransplantation vitamin A plasma levels and risk of acute graft-versus-host disease following allogeneic hematopoietic stem cell transplantation. Gjærde LK, Andersen NS, Friis LS, Kornblit B, Petersen SL, Schjødt I, Ostrowski SR, Sengeløv H.
    Bone Marrow Transplant. 2020;55(7):1457-1459. Abstract
  4. Vitamin E and acute graft-versus-host disease after myeloablative allogeneic hematopoietic cell transplantation. Gjaerde LK, Ostrowski SR, Minculescu L, Andersen NS, Friis LS, Kornblit B, Petersen SL, Schjødt I, Sengeløv H.
    Eur J Haematol. 2021;106(3):417-424. Abstract


  1. Incidence Rates and Risk Factors of Clostridioides difficile Infection in Solid Organ and Hematopoietic Stem Cell Transplant Recipients. Ilett EE, Helleberg M, Reekie J, Murray DD, Wulff SM, Khurana MP, Mocroft A, Daugaard G, Perch M, Rasmussen A, Sørensen SS, Gustafsson F, Frimodt-Møller N, Sengeløv H, Lundgren J.
    Open Forum Infect Dis. 2019;6(4):ofz086. Abstract
  2. Hyaluronic Acid Is a Biomarker for Allograft Dysfunction and Predicts 1-Year Graft Loss After Liver Transplantation. Rostved AA, Ostrowski SR, Peters L, Lundgren JD, Hillingsø J, Johansson PI, Rasmussen A.
    Transplant Proc. 2018;50(10):3635-3643. Abstract
  3. Immune function as predictor of infectious complications and clinical outcome in patients undergoing solid organ transplantation (the ImmuneMo:SOT study): a prospective non-interventional observational trial. Drabe CH, Sørensen SS, Rasmussen A, Perch M, Gustafsson F, Rezahosseini O, Lundgren JD, Ostrowski SR, Nielsen SD.
    BMC Infect Dis. 2019;19(1):573. Abstract
  4. Improved Overall Survival, Relapse-Free-Survival, and Less Graft-vs.-Host-Disease in Patients With High Immune Reconstitution of TCR Gamma Delta Cells 2 Months After Allogeneic Stem Cell Transplantation. Minculescu L, Marquart HV, Ryder LP, Andersen NS, Schjoedt I, Friis LS, Kornblit BT, Petersen SL, Haastrup E, Fischer-Nielsen A, Reekie J, Sengelov H.
    Front Immunol. 2019;10:1997. Abstract
  5. Definitions of Resistant and Refractory Cytomegalovirus Infection and Disease in Transplant Recipients for Use in Clinical Trials. Chemaly RF, Chou S, Einsele H, Griffiths P, Avery R, Razonable RR, Mullane KM, Kotton C, Lundgren J, Komatsu TE, Lischka P, Josephson F, Douglas CM, Umeh O, Miller V, Ljungman P; Resistant Definitions Working Group of the Cytomegalovirus Drug Development Forum.
    Clin Infect Dis. 2019;68(8):1420-1426. Abstract
  6. Risk Factors for Failure of Primary (Val)ganciclovir Prophylaxis Against Cytomegalovirus Infection and Disease in Solid Organ Transplant Recipients. Khurana MP, Lodding IP, Mocroft A, Sørensen SS, Perch M, Rasmussen A, Gustafsson F, Lundgren JD.
    Open Forum Infect Dis. 2019;6(6):ofz215. Abstract


  1. Extracorporeal photopheresis is a valuable treatment option in steroid-refractory or steroid-dependent acute graft versus host disease-experience with three different approaches. Nygaard M, Karlsmark T, Andersen NS, Schjødt IM, Petersen SL, Friis LS, Kornblit BT, Sengeløv H.
    Bone Marrow Transplant. 2019;54(1):150-154. Abstract
  2. Classification of death causes after transplantation (CLASS): Evaluation of methodology and initial resultsWareham NE, Da Cunha-Bang C, Borges ÁH, Ekenberg C, Gerstoft J, Gustafsson F, Hansen D, Heilmann C, Helleberg M, Hillingsø J, Krohn PS, Lodding IP, Lund TK, Lundgren L, Mocroft A, Perch M, Petersen SL, Petruskevicius I, Rasmussen A, Rossing K, Rostved AA, Sengeløv H, Sørensen VR, Sørensen SS, Lundgren JD.
    Medicine (Baltimore). 2018;97(29):e11564. Abstract
  3. The value of EBV DNA in early detection of post-transplant lymphoproliferative disorders among solid organ and hematopoietic stem cell transplant recipients. Wareham NE, Mocroft A, Sengeløv H, Da Cunha-Bang C, Gustafsson F, Heilmann C, Iversen M, Kirkby NS, Rasmussen A, Sørensen SS, Lundgren JD; MATCH in PERSIMUNE study group.
    J Cancer Res Clin Oncol. 2018;144(8):1569-1580. Abstract
  4. Impact of CMV PCR Blips in Recipients of Solid Organ and Hematopoietic Stem Cell Transplantation. Lodding IP, Mocroft A, da Cunha Bang C, Gustafsson F, Iversen M, Kirkby N, Perch M, Rasmussen A, Sengeløv H, Sørensen SS, Lundgren JD.
    Transplant Direct. 2018;4(6):e355. Abstract
  5. Cytomegalovirus (CMV) Disease Despite Weekly Preemptive CMV Strategy for Recipients of Solid Organ and Hematopoietic Stem Cell Transplantation. Lodding IP, da Cunha Bang C, Sørensen SS, Gustafsson F, Iversen M, Kirkby N, Perch M, Rasmussen A, Sengeløv H, Mocroft A, Lundgren JD.
    Open Forum Infect Dis. 2018;5(5):ofy080. Abstract
  6. Cytomegalovirus Viral Load in Bronchoalveolar Lavage to Diagnose Lung Transplant Associated CMV Pneumonia. Lodding IP, Schultz HH, Jensen JU, Kirkby N, Perch M, Andersen C, Lundgren JD, Iversen M.
    Transplantation. 2018;102(2):326-332. Abstract
  7. C-Reactive Protein Levels at Diagnosis of Acute Graft-versus-Host Disease Predict Steroid-Refractory Disease, Treatment-Related Mortality, and Overall Survival after Allogeneic Hematopoietic Stem Cell Transplantation. Minculescu L, Kornblit BT, Friis LS, Schiødt I, Petersen SL, Andersen NS, Sengeloev H.
    Biol Blood Marrow Transplant. 2018;24(3):600-607. Abstract


  1. Risk of infectious diseases among first-degree relatives of transplant recipients who develop CMV infection: is the infectious phenotype inheritable?  C Ekenberg, IP Lodding, NE Wareham, SS Sørensen, H Sengeløv, F Gustafsson, A Rasmussen, M Perch, JD Lundgren, M Helleberg
    Eur J Clin Microbiol Infect Dis. 2017;36(12):2391-2398. Abstract


  1. The clinical utility of PDG PET/CT among solid organ transplant recipients suspected of malignancy or infection.  NE Wareham, JD Lundgren, C Da Cuncha-Bang, F Gustafsson, M Iversen, HH Johannesen, A Kjær, A Rasmussen, H Sengeløv, SS Sørensen, BM Fischer.
    Eur J Nucl Med Mol Imaging. 2016 Nov 12. Abstract
  2. MELD score measured day 10 after orthotopic liver transplantation predicts death and re-transplantation within the first year.  Rostved AA, Lundgren JD, Hillingsø J, Peters L, Mocroft A, Rasmussen A.
    Scand J Gastroenterol. 2016, 51 (11), 1360-1366. Abstract


  1. Clinical Application of Variation in Replication Kinetics during Episodes of Post-Transplant Cytomegalovirus Infections. Lodding IP, Sengeløv H, da Cunha-Bang C, Iversen Rasmussen A, Gustafsson F, Downing JG, Grarup J, Kirkby N, Frederiksen CM, Mocroft A, Sørensen SS, Lundgren JD, MATCH Programme Study Group.
    EBioMedicine. 2015;2(7):699-705. Abstract


  1. The time course of development and impact from viral resistance against ganciclovir in cytomegalovirus infection. Cunha-Bang Cd, Kirkby N, Sønderholm M, Sørensen SS, Sengeløv H, Iversen M, Rasmussen A, Gustafsson F, Frederiksen CM, Kjaer J, Lepri AC, Lundgren JD.
    Am J Transplant. 2013;13(2):458-66. Abstract


  1. Factors associated with the development of cytomegalovirus infection following solid organ transplantation. da Cunha-Bang C, Sørensen SS, Iversen M, Sengeløv H, Hillingsø JG, Rasmussen A, Mortensen SA, Fox ZV, Kirkby NS, Christiansen CB, Lundgren JD.
    Scand J Infect Dis. 2011;43(5):360-5. Abstract